Aurinia Pharmaceuticals
AUPH
AUPH
65 hedge funds and large institutions have $142M invested in Aurinia Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
46% less call options, than puts
Call options by funds: $3.04M | Put options by funds: $5.61M
Holders
65
Holding in Top 10
–
Calls
$3.04M
Puts
$5.61M
Top Buyers
| 1 | +$7.25M | |
| 2 | +$3.25M | |
| 3 | +$2.53M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.15M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.23M |
Top Sellers
| 1 | -$7.34M | |
| 2 | -$5.51M | |
| 3 | -$4.03M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.94M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.94M |